Literature DB >> 28523097

Similarity- and Substructure-Based Development of β2-Adrenergic Receptor Ligands Based on Unusual Scaffolds.

Denis Schmidt1,2, Jakub Gunera1, Jillian G Baker3, Peter Kolb1.   

Abstract

The β2-adrenergic receptor (β2AR) is a G protein-coupled receptor (GPCR) and a well-explored target. Here, we report the discovery of 13 ligands, ten of which are novel, of this particular GPCR. They have been identified by similarity- and substructure-based searches using multiple ligands, which were described in an earlier study, as starting points. Of note, two of the molecules used as queries here distinguish themselves from other β2AR antagonists by their unique scaffold. The molecules described in this work allow us to explore the ligand space around the previously reported molecules in greater detail, leading to insights into their structure-activity relationship. We also report experimental binding and selectivity data and putative binding modes for the novel molecules.

Entities:  

Keywords:  SAR-by-catalog; docking; similarity searches; β2-adrenergic receptor

Year:  2017        PMID: 28523097      PMCID: PMC5430404          DOI: 10.1021/acsmedchemlett.6b00363

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  11 in total

Review 1.  The significance of G protein-coupled receptor crystallography for drug discovery.

Authors:  John A Salon; David T Lodowski; Krzysztof Palczewski
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

2.  The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.

Authors:  Jillian G Baker
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

3.  ZINC--a free database of commercially available compounds for virtual screening.

Authors:  John J Irwin; Brian K Shoichet
Journal:  J Chem Inf Model       Date:  2005 Jan-Feb       Impact factor: 4.956

Review 4.  How many drug targets are there?

Authors:  John P Overington; Bissan Al-Lazikani; Andrew L Hopkins
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

5.  High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

Authors:  Vadim Cherezov; Daniel M Rosenbaum; Michael A Hanson; Søren G F Rasmussen; Foon Sun Thian; Tong Sun Kobilka; Hee-Jung Choi; Peter Kuhn; William I Weis; Brian K Kobilka; Raymond C Stevens
Journal:  Science       Date:  2007-10-25       Impact factor: 47.728

6.  Site of action of beta-ligands at the human beta1-adrenoceptor.

Authors:  Jillian G Baker
Journal:  J Pharmacol Exp Ther       Date:  2005-02-16       Impact factor: 4.030

7.  Identification of key residues in transmembrane 4 responsible for the secondary, low-affinity conformation of the human β1-adrenoceptor.

Authors:  Jillian G Baker; Richard G W Proudman; Stephen J Hill
Journal:  Mol Pharmacol       Date:  2014-03-07       Impact factor: 4.436

8.  Anatomical profiling of G protein-coupled receptor expression.

Authors:  Jean B Regard; Isaac T Sato; Shaun R Coughlin
Journal:  Cell       Date:  2008-10-31       Impact factor: 41.582

9.  GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.

Authors:  Daniel M Rosenbaum; Vadim Cherezov; Michael A Hanson; Søren G F Rasmussen; Foon Sun Thian; Tong Sun Kobilka; Hee-Jung Choi; Xiao-Jie Yao; William I Weis; Raymond C Stevens; Brian K Kobilka
Journal:  Science       Date:  2007-10-25       Impact factor: 47.728

10.  Structure-based discovery of beta2-adrenergic receptor ligands.

Authors:  Peter Kolb; Daniel M Rosenbaum; John J Irwin; Juan José Fung; Brian K Kobilka; Brian K Shoichet
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-02       Impact factor: 11.205

View more
  1 in total

1.  Interrogating dense ligand chemical space with a forward-synthetic library.

Authors:  Florent Chevillard; Silvia Stotani; Anna Karawajczyk; Stanimira Hristeva; Els Pardon; Jan Steyaert; Dimitrios Tzalis; Peter Kolb
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-21       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.